Cargando…

Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling

Rheumatoid arthritis (RA) is closely associated with periarticular osteopenia and leads to a high risk of generalized osteoporosis. Although glucocorticoid (GC) treatment ameliorates joint degradation and manages inflammation in RA, GC application may induce further bone quality deterioration in RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiang, Wu, Qingyun, Zhang, Xinle, Tian, Jia, Liang, Dahong, Min, Yalin, Lu, Jiaqi, Zhang, Xuemei, Cui, Liao, Xu, Bilian, Liu, Yanzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450458/
https://www.ncbi.nlm.nih.gov/pubmed/34552485
http://dx.doi.org/10.3389/fphar.2021.710169
_version_ 1784569653288239104
author Gao, Xiang
Wu, Qingyun
Zhang, Xinle
Tian, Jia
Liang, Dahong
Min, Yalin
Lu, Jiaqi
Zhang, Xuemei
Cui, Liao
Xu, Bilian
Liu, Yanzhi
author_facet Gao, Xiang
Wu, Qingyun
Zhang, Xinle
Tian, Jia
Liang, Dahong
Min, Yalin
Lu, Jiaqi
Zhang, Xuemei
Cui, Liao
Xu, Bilian
Liu, Yanzhi
author_sort Gao, Xiang
collection PubMed
description Rheumatoid arthritis (RA) is closely associated with periarticular osteopenia and leads to a high risk of generalized osteoporosis. Although glucocorticoid (GC) treatment ameliorates joint degradation and manages inflammation in RA, GC application may induce further bone quality deterioration in RA patients. Current treatments for RA lack relevant strategies for the prevention and treatment of osteopenia in RA. In this study, we aimed to investigate whether salvianolate treatment ameliorated osteopenia in prednisone-treated RA rats. Lewis rats with collagen-induced arthritis (CIA) were administered prednisone (PDN) or PDN plus salvianolate (PDN+Sal) treatment for 90 days. The effects of Sal were investigated in PDN-treated CIA rats. To further evaluate the effects of Sal under inflammatory conditions, we investigated the effects of Sal treatment on the TNF-α-induced inflammatory response in MC3T3-E1 osteoblasts. Bone histomorphometry, bone mineral density (BMD), bone biomechanical properties, micro-computed tomography (micro-CT), immunohistochemistry, RT-PCR and western blot analyses were performed to evaluate the effects of Sal. The results demonstrated that RA induced bone loss and bone quality deterioration, with high bone turnover in CIA rats. PDN+Sal treatment significantly increased BMD and trabecular/cortical bone mass, suppressed inflammation, and improved bone biomechanical properties compared to CIA control and PDN treatment. PDN+Sal treatment significantly suppressed bone resorption and the RANKL and RANKL/OPG ratios compared to PDN. PDN+Sal and PDN treatment significantly inhibited TNF-α by 82 and 83%, respectively, and both suppressed inflammation in CIA rats. However, there was no significant difference between PDN+Sal and PDN treatment alone in regard to bone formation parameters or the management of inflammation and arthropathy. Sal significantly increased Osterix, OPN, and Col1a1 while decreasing RANKL, TRAF6, and TRAIL gene in TNF-α-induced MC3T3-E1 osteoblasts. Sal significantly increased Osterix, OPN and RUNX2 while decreasing NF-κB, TRAF6 and IL-1β protein in TNF-α-induced MC3T3-E1 osteoblasts. The results suggested that salvianolate treatment ameliorated osteopenia and improved bone quality in prednisone-treated RA rats, and the potential mechanism may be related to the regulation of the RANKL/RANK/OPG signaling pathway, TRAIL-TRAF6-NFκB signal axis, and downregulation of inflammatory cytokines. Salvianolate could be used as a promising supplemental therapeutic strategy to ameliorate osteopenia and improve bone quality in GC-treated RA patients.
format Online
Article
Text
id pubmed-8450458
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84504582021-09-21 Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling Gao, Xiang Wu, Qingyun Zhang, Xinle Tian, Jia Liang, Dahong Min, Yalin Lu, Jiaqi Zhang, Xuemei Cui, Liao Xu, Bilian Liu, Yanzhi Front Pharmacol Pharmacology Rheumatoid arthritis (RA) is closely associated with periarticular osteopenia and leads to a high risk of generalized osteoporosis. Although glucocorticoid (GC) treatment ameliorates joint degradation and manages inflammation in RA, GC application may induce further bone quality deterioration in RA patients. Current treatments for RA lack relevant strategies for the prevention and treatment of osteopenia in RA. In this study, we aimed to investigate whether salvianolate treatment ameliorated osteopenia in prednisone-treated RA rats. Lewis rats with collagen-induced arthritis (CIA) were administered prednisone (PDN) or PDN plus salvianolate (PDN+Sal) treatment for 90 days. The effects of Sal were investigated in PDN-treated CIA rats. To further evaluate the effects of Sal under inflammatory conditions, we investigated the effects of Sal treatment on the TNF-α-induced inflammatory response in MC3T3-E1 osteoblasts. Bone histomorphometry, bone mineral density (BMD), bone biomechanical properties, micro-computed tomography (micro-CT), immunohistochemistry, RT-PCR and western blot analyses were performed to evaluate the effects of Sal. The results demonstrated that RA induced bone loss and bone quality deterioration, with high bone turnover in CIA rats. PDN+Sal treatment significantly increased BMD and trabecular/cortical bone mass, suppressed inflammation, and improved bone biomechanical properties compared to CIA control and PDN treatment. PDN+Sal treatment significantly suppressed bone resorption and the RANKL and RANKL/OPG ratios compared to PDN. PDN+Sal and PDN treatment significantly inhibited TNF-α by 82 and 83%, respectively, and both suppressed inflammation in CIA rats. However, there was no significant difference between PDN+Sal and PDN treatment alone in regard to bone formation parameters or the management of inflammation and arthropathy. Sal significantly increased Osterix, OPN, and Col1a1 while decreasing RANKL, TRAF6, and TRAIL gene in TNF-α-induced MC3T3-E1 osteoblasts. Sal significantly increased Osterix, OPN and RUNX2 while decreasing NF-κB, TRAF6 and IL-1β protein in TNF-α-induced MC3T3-E1 osteoblasts. The results suggested that salvianolate treatment ameliorated osteopenia and improved bone quality in prednisone-treated RA rats, and the potential mechanism may be related to the regulation of the RANKL/RANK/OPG signaling pathway, TRAIL-TRAF6-NFκB signal axis, and downregulation of inflammatory cytokines. Salvianolate could be used as a promising supplemental therapeutic strategy to ameliorate osteopenia and improve bone quality in GC-treated RA patients. Frontiers Media S.A. 2021-09-06 /pmc/articles/PMC8450458/ /pubmed/34552485 http://dx.doi.org/10.3389/fphar.2021.710169 Text en Copyright © 2021 Gao, Wu, Zhang, Tian, Liang, Min, Lu, Zhang, Cui, Xu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gao, Xiang
Wu, Qingyun
Zhang, Xinle
Tian, Jia
Liang, Dahong
Min, Yalin
Lu, Jiaqi
Zhang, Xuemei
Cui, Liao
Xu, Bilian
Liu, Yanzhi
Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title_full Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title_fullStr Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title_full_unstemmed Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title_short Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
title_sort salvianolate ameliorates osteopenia and improves bone quality in prednisone-treated rheumatoid arthritis rats by regulating rankl/rank/opg signaling
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450458/
https://www.ncbi.nlm.nih.gov/pubmed/34552485
http://dx.doi.org/10.3389/fphar.2021.710169
work_keys_str_mv AT gaoxiang salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT wuqingyun salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT zhangxinle salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT tianjia salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT liangdahong salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT minyalin salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT lujiaqi salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT zhangxuemei salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT cuiliao salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT xubilian salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling
AT liuyanzhi salvianolateamelioratesosteopeniaandimprovesbonequalityinprednisonetreatedrheumatoidarthritisratsbyregulatingranklrankopgsignaling